Navigation Links
Drug Effective for Diabetic Foot Ulcers

A new study finds the drug dalteparin is beneficial for diabetic patients with severe foot ulcers.// Chronic foot ulcers cause a lot of suffering for diabetic patients and are one of the most expensive diabetic complications. This common complication can threaten the life and limb of the diabetic patient. A new study led by investigators from Karolinska Hospital in Sweden reveals at the effect of the drug dalteparin on foot ulcers in diabetic patients.

For the study, 87 patients were randomly assigned to receive either injections of dalteparin or an injection of a saline solution each day for up to six months. Researchers tracked each patient’s progress to see if the foot ulcer healed or if the patient ended up needing their foot amputated.

Researchers report the patients on dalteparin fared much better than the patients receiving the saline solution. Specifically, 29 patients of the 43 on dalteparin had their ulcers healed or at least saw a 50 percent improvement. In contrast, 20 of the 42 patients in the placebo group saw an improvement. Five patients in both groups had their ulcers get worse. As for amputation, two patients in the dalteparin group had their foot amputated compared to eight in the placebo group.

Study authors write, "The present study shows for the first time that treatment with dalteparin improves the ulcer outcomes in diabetic patients." Researchers add these results need to be confirmed in a larger trial. However, they say the positive effects of this drug on ulcer healing could affect the costs and care of diabetics
'"/>




Page: 1

Related medicine news :

1. New Way to "See" Genes, Evaluate Effectiveness of Gene Therapies Discovered
2. Inhaled Steroids Safe & Effective for Children with Asthma
3. ZD1839 Proves Effective - A Breakthrough in fighting Lung Cancer
4. Fluoride Found Effective in Osteoporosis
5. Aspirin and Warfarin Are Equally Effective for Stroke Prevention
6. Implantable Contact Lens Found Safe and Effective
7. Effective And Economical Agent For Anthrax
8. Stem Cell Transplants May Be Effective For MS Patients
9. Effective therapy for Huntingtons disease
10. Chemotherapy Effective for Bladder Cancer
11. Drug Effective for Vascular Dementia
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/17/2017)... MA (PRWEB) , ... August 17, 2017 , ... ... home care professionals, today announced that it has raised $1.675 M in seed ... , Rethink Education, Lumina Foundation, and Techstars Venture Capital Fund are the company’s ...
(Date:8/17/2017)... ... 2017 , ... Advice Media, the industry leader in digital marketing for medical practices, has been ... been included in the Inc. 5000 for the second time in two years. Shawn Miele, ... Inc. 5000 rankings for the second year in a row. It’s extremely difficult to make ...
(Date:8/17/2017)... ... August 17, 2017 , ... Navigating ... a Florida-based oncology business advisor to oncology practices, announced today the results of ... of attributable savings from resolving critical clinical issues that would have otherwise resulted ...
(Date:8/16/2017)... , ... August 16, 2017 , ... An August 3rd article on Reuters ... subject of a report in JAMA (the Journal of the American Medical Association). The study ... able to achieve BMIs under 30, when compared to patients with lower BMIs. At present, ...
(Date:8/16/2017)... GA (PRWEB) , ... August 16, 2017 , ... ... new Inc. 5000. The company ranked #4429 on the newly released, 36th annual ... list represents a unique look at the most successful companies within the American economy’s ...
Breaking Medicine News(10 mins):
(Date:8/7/2017)... Aug. 7, 2017 Insightin Health, provider ... retention, and engagement, announced the selection of ... Product Development, effective as of February 2017. In this ... implementation strategy for our clients. Wood brings with ... consulting and business analytics within the healthcare industry. ...
(Date:8/7/2017)... Aug. 7, 2017  Diplomat Pharmacy, Inc. (NYSE: DPLO), the ... quarter ended June 30, 2017.  All comparisons, unless otherwise noted, ... Second Quarter 2017 Highlights include: ... $1,089 million, an increase of 3.5% Total ... Gross margin of 7.5% versus 7.6% ...
(Date:8/4/2017)...  Agragen, LLC, a Cincinnati ... nutraceutical, and aquacultural feed sectors, announces a significant ... candidates, AGR131.  This drug is designed to trap ... of patients suffering from inflammatory conditions such as ... Biological pharmaceuticals currently ...
Breaking Medicine Technology: